Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NAPROXEN\NAPROXEN Cause Product use issue? 153 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 153 reports of Product use issue have been filed in association with NAPROXEN\NAPROXEN. This represents 13.2% of all adverse event reports for NAPROXEN\NAPROXEN.

153
Reports of Product use issue with NAPROXEN\NAPROXEN
13.2%
of all NAPROXEN\NAPROXEN reports
83
Deaths
127
Hospitalizations

How Dangerous Is Product use issue From NAPROXEN\NAPROXEN?

Of the 153 reports, 83 (54.2%) resulted in death, 127 (83.0%) required hospitalization, and 131 (85.6%) were considered life-threatening.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NAPROXEN\NAPROXEN. However, 153 reports have been filed with the FAERS database.

What Other Side Effects Does NAPROXEN\NAPROXEN Cause?

Fatigue (502) Mobility decreased (467) Off label use (462) Fibromyalgia (456) Folliculitis (449) Joint swelling (448) Psoriatic arthropathy (445) Glossodynia (434) General physical health deterioration (433) Hand deformity (431)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which NAPROXEN\NAPROXEN Alternatives Have Lower Product use issue Risk?

NAPROXEN\NAPROXEN vs NAPROXEN\PSEUDOEPHEDRINE NAPROXEN\NAPROXEN vs NAPROXEN\SUMATRIPTAN NAPROXEN\NAPROXEN vs NARATRIPTAN NAPROXEN\NAPROXEN vs NASONEX NAPROXEN\NAPROXEN vs NATALIZUMAB

Related Pages

NAPROXEN\NAPROXEN Full Profile All Product use issue Reports All Drugs Causing Product use issue NAPROXEN\NAPROXEN Demographics